Lv11
20 积分 2025-06-11 加入
Zexie-Baizhu Decoction ameliorates non-alcoholic fatty liver disease through gut-adipose tissue crosstalk
10天前
已完结
Gut Microbiota and Bile Acid Metabolism in the Mechanism of Ginsenoside Re Against Nonalcoholic Fatty Liver Disease
11天前
已完结
Bile acids engage the SIPR-STAT3 signaling axis to modulate regulatory T cell responses in fibrosing cholangiopathies
11天前
已完结
Bile acids and the gut microbiota: metabolic interactions and impacts on disease
11天前
已完结
Network pharmacology to unveil the mechanism of Moluodan in the treatment of chronic atrophic gastritis
15天前
已完结
Unravelling the mechanisms of Erchen decoction in the treatment of nonalcoholic fatty liver disease (NAFLD): an integrative study combining network pharmacology, molecular docking, molecular dynamics simulation, multi-omics analysis, and experimental validation
19天前
已完结
EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
19天前
已完结
Current status and future trends of the global burden of MASLD
19天前
已完结
Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH
20天前
已完结
MASLD: a systemic metabolic disorder with cardiovascular and malignant complications
20天前
已完结
皖公网安备34019202002308
